Analyst Recommendations
RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the...
February 4, 2026 EMR -0.33%
Exane BNP Paribas analyst issues OUTPERFORM recommendation for PEP on February 4, 2026 12:08PM ET. The previous analyst recommendation was Outperform.PEP was trading at $162.85 at issue of...
February 4, 2026 PEP -0.46%
Barclays analyst issues UNDERWEIGHT recommendation for GWW on February 4, 2026 10:56AM ET. The previous analyst recommendation was Underweight.GWW was trading at $1155 at issue of the analyst...
February 4, 2026 GWW -0.62%
Wells Fargo analyst issues POSITIVE recommendation for EMR on February 4, 2026 11:31AM ET. The previous analyst recommendation was Positive.EMR was trading at $152.1 at issue of the...
February 4, 2026 EMR -0.33%
Citigroup analyst issues BUY recommendation for EMR on February 4, 2026 11:35AM ET. The previous analyst recommendation was Buy.EMR was trading at $152.1 at issue of the analyst...
February 4, 2026 EMR -0.33%
Citigroup analyst issues NEUTRAL recommendation for ITW on February 4, 2026 11:36AM ET. The previous analyst recommendation was Neutral.ITW was trading at $278.91 at issue of the analyst...
February 4, 2026 ITW -1.17%
Wells Fargo analyst issues UNDERWEIGHT recommendation for ITW on February 4, 2026 11:37AM ET. The previous analyst recommendation was Underweight.ITW was trading at $278.91 at issue of the...
February 4, 2026 ITW -1.17%
Citigroup analyst issues BUY recommendation for PEP on February 4, 2026 11:39AM ET. The previous analyst recommendation was Buy.PEP was trading at $162.85 at issue of the analyst...
February 4, 2026 PEP -0.46%
Goldman Sachs analyst issues SELL recommendation for ITW on February 3, 2026 10:38PM ET. The previous analyst recommendation was Sell.ITW was trading at $278.91 at issue of the...
February 3, 2026 ITW -1.17%